广州天宝颂原生物科技开发有限公司

Guangzhou Tebsun Bio-tech Development Co.,Ltd was established in 2007 and is headquartered in Guangzhou. The company is committed to the development, production and sales of point-of-care testing (POCT) products (including reagents and instruments) in the biomedical in vitro diagnostic industry, which is a leading supplier of POCT solutions both of domestic and overseas. Since its establishment of 11 years, the company has independently researched fluorescent immunodetection technology, developed the world's only bio-fluorescent marker, and successfully applied it in the field of medical clinical testing. At present, 30 medical device products have been registered, including cardio-cerebrovascular diseases, renal functions, infections and other series of fluorescent immunodetection reagents and related supporting equipment; core technology has applied for 74 patents for protection, including 48 authorizations and 20 authorized invention patents.   The performance of TEBSUN's original products ranks the leading position in the global POCT industry. The test performance is comparable to the large automation platforms of internationally renowned brands, which has the advantages of fast, convenient, accurate and complete product lines. The products developed by the company cover cardiovascular series, infection and inflammation series, renal function and gynecological and pediatric immunoassays. It has the most complete product line in the industry both of domestic and overseas, and the product line is extremely expandable and continues to be updated with new products launch.